H1B Report
Side-by-side comparison

Belcher Pharmaceuticals, LLC vs TATA CONSULTANCY SERVICES LIMITED

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Belcher Pharmaceuticals, LLC
FLRank #FEIN 27-2953742
Entity B
TATA CONSULTANCY SERVICES LIMITED
MDRank #3FEIN 98-0429806

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricBelcher Pharmaceuticals, LLCTATA CONSULTANCY SERVICES LIMITED
Total filings171128,379
Certified %97.08%99.22%
Denied %1.17%0.15%
Withdrawn %1.75%0.50%
Cert-withdrawn %0.00%0.13%
Rank#3
Active yearsFY2010–FY2026FY2010–FY2026
Worksite stateFLMD

Outcomes — Belcher Pharmaceuticals, LLC

DOL case-status mix.

Outcome breakdown: Certified 97.1%, Withdrawn 1.8%, Denied 1.2%
Outcome breakdown
OutcomeShare
Certified97.1%
Withdrawn1.8%
Denied1.2%
Certified97.1%
Withdrawn1.8%
Denied1.2%

Outcomes — TATA CONSULTANCY SERVICES LIMITED

DOL case-status mix.

Outcome breakdown: Certified 99.2%, Cert-withdrawn 0.1%, Withdrawn 0.5%, Denied 0.1%
Outcome breakdown
OutcomeShare
Certified99.2%
Cert-withdrawn0.1%
Withdrawn0.5%
Denied0.1%
Certified99.2%
Cert-withdrawn0.1%
Withdrawn0.5%
Denied0.1%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Belcher Pharmaceuticals, LLC
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20109
FY201111
FY201210
FY20135
FY201412
FY201510
FY20168
FY201716
FY201817
FY201921
FY20203
FY20211
FY20220
FY20235
FY202411
FY202522
FY202610
TATA CONSULTANCY SERVICES LIMITED
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20101,008
FY20115,386
FY20126,700
FY20138,724
FY201413,977
FY201516,514
FY201613,100
FY201713,511
FY201814,583
FY201911,853
FY202023
FY202115
FY202211
FY20232,459
FY20249,708
FY20257,886
FY20262,921

Top 5 occupations — Belcher Pharmaceuticals, LLC

Top 5 occupations — TATA CONSULTANCY SERVICES LIMITED

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.